Homozygous 2p11.2 deletion supports the implication of ELMOD3 in hearing loss and reveals the potential association of CAPG with ASD/ID etiology.
Autism
CAPG
CNV
ELMOD3
Hearing loss
homozygous deletion
Journal
Journal of applied genetics
ISSN: 2190-3883
Titre abrégé: J Appl Genet
Pays: England
ID NLM: 9514582
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
20
08
2018
accepted:
27
09
2018
revised:
25
09
2018
pubmed:
5
10
2018
medline:
17
5
2019
entrez:
5
10
2018
Statut:
ppublish
Résumé
Autism spectrum disorder (ASD) is a set of neurodevelopmental conditions characterized by early-onset difficulties in social communication and unusually restricted, repetitive behavior and interests. Parental consanguinity may lead to higher risk of ASD and to more severe clinical presentations in the offspring. Studies of ASD families with high inbreeding enable the identification of inherited variants of this disorder particularly those with an autosomal recessive pattern of inheritance. In our study, using copy number variants (CNV) analysis, we identified a rare homozygous deletion in 2p11.2 region that affects ELMOD3, CAPG, and SH2D6 genes in a boy with ASD, intellectual disability (ID), and hearing impairment (HI). This deletion may reveal a new contiguous deletion syndrome in which ELMOD3, known to be implicated in autosomal recessive deafness underlies the HI of the proband and CAPG, member of actin regulatory proteins involved in cytoskeletal dynamic, an important function for brain development and activity, underlies the ASD/ID phenotype. A possible contribution of SH2D6 gene, as a part of a chimeric gene, to the clinical presentation of the patient is discussed. Our result supports the implication of ELMOD3 in hearing loss and highlights the potential clinical relevance of 2p11.2 deletion in autism and/or intellectual disability.
Identifiants
pubmed: 30284680
doi: 10.1007/s13353-018-0472-3
pii: 10.1007/s13353-018-0472-3
doi:
Substances chimiques
ELMOD3 protein, human
0
GTPase-Activating Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-56Références
J Cell Biol. 2001 Aug 20;154(4):775-84
pubmed: 11514591
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7763-8
pubmed: 15128950
J Med Genet. 2006 Nov;43(11):843-9
pubmed: 16840569
Nucleic Acids Res. 2007;35(6):2013-25
pubmed: 17341461
Genome Res. 2007 Nov;17(11):1665-74
pubmed: 17921354
Science. 2008 Jul 11;321(5886):218-23
pubmed: 18621663
J Med Genet. 2010 Jan;47(1):22-9
pubmed: 19592390
J Cell Biol. 2010 May 17;189(4):619-29
pubmed: 20457765
Neuron. 2011 Jun 9;70(5):886-97
pubmed: 21658582
Sci Signal. 2011 Dec 06;4(202):ra83
pubmed: 22155787
Curr Opin Genet Dev. 2012 Jun;22(3):229-37
pubmed: 22463983
Child Dev. 2013 Jan-Feb;84(1):121-32
pubmed: 23311723
Neuron. 2013 Jan 23;77(2):235-42
pubmed: 23352160
Cell Adh Migr. 2013 Jul-Aug;7(4):379-87
pubmed: 23628914
PLoS Genet. 2013;9(9):e1003774
pubmed: 24039609
Am J Hum Genet. 2013 Oct 3;93(4):697-710
pubmed: 24094746
Nat Rev Neurosci. 2015 Sep;16(9):551-63
pubmed: 26289574
Ann Hum Genet. 2016 May;80(3):187-96
pubmed: 27000383
Nature. 2017 Apr 12;544(7649):235-239
pubmed: 28406212
Int J Genomics. 2017;2017:4798474
pubmed: 28630856
J Autism Dev Disord. 2018 Feb;48(2):442-449
pubmed: 29027068
Hum Genet. 2018 Apr;137(4):329-342
pubmed: 29713870
Genomics. 1994 Oct;23(3):560-5
pubmed: 7851883